Diabetes and nonalcoholic Fatty liver disease: a pathogenic duo.
about
Identification of isosilybin a from milk thistle seeds as an agonist of peroxisome proliferator-activated receptor gammaExtracellular Vesicles: A New Frontier in Biomarker Discovery for Non-Alcoholic Fatty Liver DiseaseMicroRNAs as controlled systems and controllers in non-alcoholic fatty liver diseaseInsulin resistance as a physiological defense against metabolic stress: implications for the management of subsets of type 2 diabetesEpidemiology of fatty liver: an updateThe Potential Mechanisms of Berberine in the Treatment of Nonalcoholic Fatty Liver DiseaseThe role of the p53 tumor suppressor in metabolism and diabetesGenomic profiling of type-1 adult diabetic and aged normoglycemic mouse liver.NAFLD Susceptibility Genes and their Association with Type 2 Diabetes and Obesity in a New Mexico Population.Nonalcoholic fatty liver disease and cardiovascular diseasePredicting hepatic steatosis in a racially and ethnically diverse cohort of adolescent girls.Comments on 'low serum sex hormone binding globulin is associated with nonalcoholic fatty liver disease in type 2 diabetic patients'Elevated serum ferritin level is associated with the incident type 2 diabetes in healthy Korean men: a 4 year longitudinal study.Berberine ameliorates nonalcoholic fatty liver disease by a global modulation of hepatic mRNA and lncRNA expression profilesQuantitative analysis of the murine lipid droplet-associated proteome during diet-induced hepatic steatosis.Bidirectional association between nonalcoholic fatty liver disease and type 2 diabetes in Chinese population: Evidence from the Dongfeng-Tongji cohort study.The Burden of NAFLD and Its Characteristics in a Nationwide Population with Type 2 Diabetes.De novo lipogenesis in the liver in health and disease: more than just a shunting yard for glucoseOxidant status and lipid composition of erythrocyte membranes in patients with type 2 diabetes, chronic liver damage, and a combination of both pathologies.Microarray analysis of gene expression in liver, adipose tissue and skeletal muscle in response to chronic dietary administration of NDGA to high-fructose fed dyslipidemic ratsLiver Mitochondrial DNA Copy Number and Deletion Levels May Contribute to Nonalcoholic Fatty Liver Disease Susceptibility.Novel curcumin derivative CNB-001 mitigates obesity-associated insulin resistance.Modified SJH alleviates FFAs-induced hepatic steatosis through leptin signaling pathways.Immune cells and metabolic dysfunction.Intracellular lipid accumulation and shift during diabetes progression.A novel hepatokine, HFREP1, plays a crucial role in the development of insulin resistance and type 2 diabetes.Genome-wide analysis of long noncoding RNA expression profiles in patients with non-alcoholic fatty liver disease.Early-life exposure to substance abuse and risk of type 2 diabetes in adulthood.PPARs: regulators of metabolism and as therapeutic targets in cardiovascular disease. Part I: PPAR-α.Detrimental effects of nicotine on thioacetamide-induced liver injury in mice.Patients With Diabetes and Chronic Liver Disease Are at Increased Risk for Overall Mortality: A Population Study From the United States.Endoplasmic reticulum proteostasis in hepatic steatosis.Serum transforming growth factor beta 3 predicts future development of nonalcoholic fatty liver disease.Non-alcoholic fatty liver disease predicts type 2 diabetes mellitus, but not prediabetes, in Xi'an, China: a five-year cohort study.The pro-fibrotic role of dipeptidyl peptidase 4 in carbon tetrachloride-induced experimental liver injury.Effects of Bariatric Surgery on Liver Function Tests in Patients with Nonalcoholic Fatty Liver Disease.Low alanine aminotransferase levels and higher number of cardiovascular events in people with Type 2 diabetes: analysis of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.Hard clinical outcomes in patients with NAFLD.Circulating dipeptidyl peptidase-4 activity correlates with measures of hepatocyte apoptosis and fibrosis in non-alcoholic fatty liver disease in type 2 diabetes mellitus and obesity: A dual cohort cross-sectional study.Dipeptidylpeptidase-IV activity and expression reveal decreased damage to the intrahepatic biliary tree in fatty livers submitted to subnormothermic machine-perfusion respect to conventional cold storage.
P2860
Q24567657-DA4841B9-E331-4716-B783-3771185E2B76Q26764843-8AB4EE21-30A4-484B-A19D-7060B6564832Q26852606-525217F3-861B-472E-8A24-B3BA79741E6FQ26866924-7F1A2130-E70C-4971-AEA3-7C9E52EB1622Q27000114-2B6CB923-1B5D-45E9-AB8A-94277BACA44CQ28078754-F287EF06-8946-4BF1-8044-1A8D05D8F150Q28079903-25453B91-F4FD-4B8D-A6BF-3ECF2B0F18C7Q33592783-DCCEBE45-044E-4681-B99E-FD8506F1DF48Q33768820-80D26269-07F3-458D-95F8-94814D46D8A8Q33886952-BAFAC4B5-B053-4B9A-A261-3876499065FBQ34040931-BB3E85A7-29E4-458F-B88F-DE86768E3102Q34241481-88C775F1-D273-4149-9F74-701688FCD485Q35009970-751B4C0D-0B8F-44F2-B2BB-8C0674A6DEA2Q35047942-B23762ED-CD7E-46C1-807E-5C2E7AAFECB3Q36307276-2774EB44-9663-4BE8-904C-9F06847D9593Q36325487-8FD3BB16-CB08-48C0-AF24-5DC4389FBC69Q36792804-7DAAB4D6-9375-46BD-AD62-9D29BDE6F6C2Q36800168-00FF04E7-1333-4E85-8BF8-570DC782A9BFQ36949957-E5BC5B50-6441-4A9B-B6AC-ED45A0104666Q37294679-E1EFE0C0-2423-4D6F-B7FD-A137FBD0A2E5Q37587055-43E9F84E-0F1A-45E9-9542-485FBA72DDDDQ37707726-2FC6A27C-80D1-45EE-B8E5-BA3687E05349Q37727871-A6287F76-0A4F-4EF3-9C03-B24C4A7B8307Q38161295-B75A9C4B-976F-4F4E-80C9-578DB245C970Q38232287-CC03E21A-77A0-48A2-A5F1-51BE5BAEE8FCQ38292347-43BA6964-2A2E-440E-AF5F-4F5615298739Q38456347-AC221576-962B-42FC-A11D-573B5DD25467Q38528280-FF258E75-10E1-4EB7-9EE9-52B231E94C56Q38674742-02CE5B41-650A-40E7-89DC-415DE314B68AQ38706239-ECD05E0E-D0F1-4260-A79E-B4F5FE7EAD3CQ38820018-09FF43BD-E455-4D4D-84E9-2117495E5A67Q38925531-C8328B22-20F2-40C2-846D-31839E62B403Q38996795-A6BCADDD-6AB2-4DB4-B4A7-37826CA83829Q39017557-336E7000-20D3-49CE-947D-9EB57914C375Q39144304-44F5972D-6E27-43DA-BAC7-F0D57A3E730BQ40426243-533974B9-C89E-4E50-BB88-6B287A2EB725Q40471167-51CFB22C-079D-4CA8-9794-CCD3D5DBBAEAQ40706265-7ED0DDCB-4F76-422C-B120-D5DFCCD58E0EQ41686499-BAD859F6-2212-4F9C-9C2F-8984ADADDBBAQ41851708-76458B65-7F2F-4544-82D5-70B381751353
P2860
Diabetes and nonalcoholic Fatty liver disease: a pathogenic duo.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Diabetes and nonalcoholic Fatty liver disease: a pathogenic duo.
@en
type
label
Diabetes and nonalcoholic Fatty liver disease: a pathogenic duo.
@en
prefLabel
Diabetes and nonalcoholic Fatty liver disease: a pathogenic duo.
@en
P2093
P356
P1433
P1476
Diabetes and nonalcoholic Fatty liver disease: a pathogenic duo.
@en
P2093
K H Williams
M D Gorrell
N A Shackel
S V McLennan
P304
P356
10.1210/ER.2012-1009
P577
2012-12-13T00:00:00Z